Understanding health equity in patient-reported outcomes.

allergy/immunology health disparities health equity patient-reported outcomes

Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
20 Apr 2024
Historique:
received: 21 03 2024
revised: 08 04 2024
accepted: 11 04 2024
medline: 23 4 2024
pubmed: 23 4 2024
entrez: 22 4 2024
Statut: aheadofprint

Résumé

Patient reported outcomes (PROs) are measures of patients' health that are conveyed directly by individual patients. These measures serve as instruments to evaluate the impact of interventions on any aspect of patients' health, from specific symptoms to broader quality-of-life indicators. However, their effectiveness relies on capturing relevant factors accurately. While commonly utilized in clinical trials, PROs extend their influence across healthcare settings, informing clinicians, healthcare payers, regulators, and administrators to guide quality improvement and reimbursement decisions. Neglecting health equity considerations in PRO development and implementation widens health disparities, leading to biased interpretations, medical mismanagement, and poor health outcomes among minoritized groups. To foster equitable healthcare, efforts must focus on considering the values of underrepresented populations in PRO design, addressing barriers to completion, enhancing representation in research, providing cultural competency training for clinicians, and allocating research funding to support health equity research. By addressing these issues, advances can be made towards fostering inclusive, equitable healthcare for all individuals.

Identifiants

pubmed: 38648977
pii: S2213-2198(24)00407-0
doi: 10.1016/j.jaip.2024.04.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Lourdes G Ramirez (LG)

Division of Allergy and Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: lgramirez@bwh.harvard.edu.

Margee Louisias (M)

Division of Allergy and Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: mlouisias@bwh.harvard.edu.

Princess U Ogbogu (PU)

Division of Pediatric Allergy, Immunology, and Rheumatology, University Hospitals Rainbow Babies and Children's Hospital, Cleveland, Ohio; Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address: Princess.Ogbogu@UHhospitals.org.

Alanna Stinson (A)

Section of Allergy, Immunology and Pediatric Pulmonology, Department of Pediatrics, The University of Chicago, Chicago, IL, USA. Electronic address: Alanna.Stinson@bsd.uchicago.edu.

Ruchi Gupta (R)

Center for Food Allergy & Asthma Research, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. Electronic address: r-gupta@northwestern.edu.

Samantha Sansweet (S)

Center for Food Allergy & Asthma Research, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. Electronic address: samantha.sansweet@northwestern.edu.

Tarandeep Singh (T)

Section of Allergy and Immunology, Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: Tarandeep.Singh@Pennmedicine.upenn.edu.

Andrea Apter (A)

Section of Allergy and Immunology, Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: Andrea.Apter@pennmedicine.upenn.edu.

Bridgette L Jones (BL)

Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Children's Mercy Hospital, Section of Allergy/Immunology and Division of Pediatric Clinical Pharmacology and Therapeutic Innovation, Kansas City, MO. Electronic address: bljones@cmh.edu.

Sharmilee M Nyenhuis (SM)

Section of Allergy, Immunology and Pediatric Pulmonology, Department of Pediatrics, The University of Chicago, Chicago, IL, USA. Electronic address: snyenhuis@bsd.uchicago.edu.

Classifications MeSH